PROTEGE RX CAROTID STENT SYSTEM
Report
- Report Number
- 2183870-2018-00150
- Event Type
- Injury
- Date Received
- March 23, 2018
- Date of Event
- October 20, 2017
- Report Date
- March 23, 2018
- Manufacturer
- COVIDIEN
- Product Code
- NIM
- PMA / PMN Number
- P060001
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- GM
- Reporter Occupation
- PHYSICIAN
Narratives
AVERAGE AGE, MAJORITY GENDER,EVENT DATE IS LITERATURE ARTICLE PUBLISHED ONLINE DATE RECURRENT STENOSIS FOLLOWING CAROTID ARTERY STENTING TREATED WITH A DRUG-ELUTING BALLOON: A SINGLE-CENTER RETROSPECTIVE ANALYSIS C. POHLMANN & J. HÖLTJE & M. ZEILE & F. BONK & P. P. URBAN & R. BRÜNING NEURORADIOLOGY (2018) 60:81¿87 DOI.ORG/10.1007/S00234-017-1935-7. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.
THE JOURNAL DOCUMENTS A RETROSPECTIVE SINGLE CENTER ANALYSIS OF PATIENTS WITH CAROTID ARTERY STENTING BETWEEN 2009 AND 2015. NINE PATIENTS WITH HIGH-GRADE CAROTID ARTERY IN STENT RESTENOSIS WERE IDENTIFIED. IN THE ORIGINAL INDEX PROCEDURES, ALL PATIENTS HAD CAROTID ARTERY STENTING CARRIED OUT. A PROTEGE CAROTID STENT WAS USED IN ONE PATIENT WHILE NON-MDT DEVICES WERE USED IN THE OTHER EIGHT PATIENTS. RESTENOSIS OCCURRED IN ALL PATIENTS POST PROCEDURE. ALL NINE PATIENTS WERE THEN RETREATED USING DRUG ELUTING BALLOONS. MEDTRONIC IN.PACT AMPHIPRION BALLOONS WERE USED IN FIVE OF THESE PROCEDURES. RESTENOSIS OCCURRED IN ONE PATIENT DURING THE FOLLOW UP PERIOD POST DEB TREATMENT. THERE WERE NO PRODUCT PROBLEMS AND NO OTHER ADVERSE EVENTS REPORTED IN CASES WHERE A MEDTRONIC DEVICE WAS USED. TWO DEATHS OCCURRED DURING THE FOLLOW UP PERIOD: ONE DECEASED DUE TO A BRONCHIAL CARCINOMA AND THE OTHER DECEASED DUE TO UROSEPSIS. BOTH DEATHS WERE UNRELATED TO THE DEB TREATMENT.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 210554 | PROTEGE RX CAROTID STENT SYSTEM | STENT, CAROTID | NIM | COVIDIEN |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 66 YR | Required Intervention |